Delivery Order SPE2DB24D1205-SPE2DB25FDANW
Award Date 9/16/25
Potential Completion Date 10/7/25
Potential Value $8.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, valued at $8,888.50 with a firm fixed price arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $7,110.80 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is...
- The Defense Logistics Agency awarded a $8,888.50 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a therapeutic oncology medication, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $42,664.80 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Enhertu 100 mg vials valued at $10,666.20 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award involved no set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a delivery order valued at $14,221.60 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty oncology medication, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 6, 2025, was competitively awarded without set-aside designation and is scheduled for completion by August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,666.20 for 100 mg vials of Enhertu, an oncology medication, on September 8, 2025, with completion scheduled for September 29, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December...
- The Defense Logistics Agency awarded a $17,777.00 delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, a specialty oncology medication. This firm fixed price contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The award was competitively granted without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty pharmaceutical product, with a ceiling value of $7,110.80. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 29, 2025. The award leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...